Gene: COG7
Official Full Name: component of oligomeric golgi complex 7provided by HGNC
Gene Summary: The protein encoded by this gene resides in the golgi, and constitutes one of the 8 subunits of the conserved oligomeric Golgi (COG) complex, which is required for normal golgi morphology and localization. Mutations in this gene are associated with the congenital disorder of glycosylation type IIe.[provided by RefSeq, May 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23323 | COG7 Knockout cell line (HeLa) | Human | COG7 | 1:3~1:6 | Negative | Online Inquiry |
KO23324 | COG7 Knockout cell line (HCT 116) | Human | COG7 | 1:2~1:4 | Negative | Online Inquiry |
KO23325 | COG7 Knockout cell line (HEK293) | Human | COG7 | 1:3~1:6 | Negative | Online Inquiry |
KO23326 | COG7 Knockout cell line (A549) | Human | COG7 | 1:3~1:4 | Negative | Online Inquiry |
COG7 Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to lack the expression of the COG7 gene, a critical component of the Conserved Oligomeric Golgi (COG) complex. This gene plays a vital role in intracellular trafficking and the proper functioning of the Golgi apparatus, which is essential for glycoprotein and glycolipid synthesis. By creating targeted knockout cell lines, researchers can rigorously investigate the cellular consequences of COG7 absence, providing insights into the mechanisms of glycosylation and the role of the Golgi in various cellular processes.
The primary function of these knockout cell lines is to facilitate the study of Golgi dynamics, trafficking pathways, and the implications of disrupted glycosylation patterns in disease states. The absence of COG7 can lead to altered protein processing and trafficking, serving as a model for understanding diseases characterized by Golgi dysfunction, including certain congenital disorders of glycosylation. These cell lines serve as invaluable tools for biochemical assays, drug discovery, and the investigation of cell signaling pathways.
From a scientific perspective, the COG7 Gene Knockout Cell Lines present unique advantages over alternative models. With precision gene editing techniques like CRISPR-Cas9, these cell lines exhibit stable, reproducible knockout conditions that allow for consistent experimental results. Moreover, they offer a direct avenue for investigating the effects of COG7 disruption in both physiological and pathological contexts, which is crucial for advancing our understanding of related diseases.
For researchers and clinicians alike, the COG7 Gene Knockout Cell Lines represent a powerful asset, especially for those focused on glycosylation research, cell biology, and the development of therapeutic strategies targeting Golgi-associated defects. By using these specialized models, users can accelerate their research endeavors and contribute to advancements in molecular biology and medicine.
Our company is dedicated to providing high-quality biological products, supported by a robust foundation in genetic engineering and cell biology. With our expertise, we ensure that you receive not only exceptional products but also the scientific support needed to harness their full potential in your research or clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.